Your browser doesn't support javascript.
loading
Combinations of cefoxitin plus other ß-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.
Banerjee, R; Fernandez, M G; Enthaler, N; Graml, C; Greenwood-Quaintance, K E; Patel, R.
Afiliación
  • Banerjee R; Division of Pediatric Infectious Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Banerjee.ritu@mayo.edu
Eur J Clin Microbiol Infect Dis ; 32(6): 827-33, 2013 Jun.
Article en En | MEDLINE | ID: mdl-23340864
In vitro studies demonstrate that oxacillin minimal inhibitory concentrations (MICs) of methicillin-resistant S. aureus (MRSA) strains USA300 and 400 decrease in the presence of cefoxitin. The aim of this study was to characterize the activity of cefoxitin plus ß-lactams against a collection of MRSA isolates. We assessed the in vitro antimicrobial activity of a selection of ß-lactams alone and together with subinhibitory concentrations of cefoxitin against a collection of MRSA, methicillin-susceptible S. aureus (MSSA), and vancomycin-intermediate S. aureus (VISA) isolates using MICs and time kill assays. For community-associated (CA) MRSA strains USA300 and USA400, MICs of nafcillin, cefazolin, cephalexin, cefuroxime, ceftriaxone and cefotaxime decreased by 8- to 64-times in the presence of 10 µg/ml cefoxitin. In contrast, for hospital-associated (HA) strains COLn, N315, and Mu50, there was no change in any ß-lactam MIC in the presence of cefoxitin. When combined with cefoxitin, the cephalexin MIC decreased for eight CA-MRSA and five MSSA sequence types but did not change for seven HA-MRSA sequence types. ß-lactam/cefoxitin combinations were synergistic against CA- but not HA-MRSA strains in time kill assays. Cefoxitin combined with a variety of ß-lactams enhances their activity against CA-MRSA strains in vitro. Further studies of combination ß-lactam therapy may provide insight into ß-lactam biology, penicillin binding protein cooperativity, and novel therapeutic strategies against MRSA.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Cefoxitina / Beta-Lactamas / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Estafilocócicas / Cefoxitina / Beta-Lactamas / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Clin Microbiol Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Año: 2013 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania